The Patient Engagement Plan is a roadmap for how, when, and why your team wants to engage with patients and care partners throughout an asset's lifecycle.
Why do it?
Deeper insights for better products
Faster to market
When you develop an L-PEP with us, you will have:
- Understand what really matters to the patients you serve
- Develop the evidence needed for stakeholder decision making including patients’ who will ultimately make their health care choices
- Prioritize use of resources by understanding patients’ unique and valuable perspectives directly from them
- Increase awareness of clinical trial opportunities with the right patient populations for your trial
- Design studies that patients want to enroll in and stay in until the end
- Build partnerships with participants and communities
- Build trust and enhance your reputation with patients and communities through demonstrated actions and commitment
- Innovate more products of value for patients and your company
- Lead your company with greater connection with patients in the process of R&D for a sense of purpose and urgency to deliver on the needs of those you serve
A refined and effective process to bring internal cross-functional teams together to develop a roadmap specifically focused on optimizing patient engagement opportunities for a given asset from R&D into commercialization, resulting in a Plan that can be incorporated into an asset’s overall strategy.
Many companies see opportunities to bring insights from patients living with a given condition to inform decisions on endpoint selection, informed consent language, adequacy of Patient-Reported Outcome measure in assessing what really matters to patients only weeks before the need arises. This is too late. Quality Patient Engagement requires planning to help ensure the right patient voices are represented, with various elements of diversity, whether geographic, age, sexual orientation, race/ethnicity, or stage of disease, for example. Planning and prioritizing when, why, and how insights from patients will be obtained allow for optimizing opportunities, budgeting, and maximizing insights for key internal and external decision-making (regulatory and payer) to best support clinical development and evidence generation.
We form a core team with key leaders of a program or project team, and complete pre-work using existing source documents (e.g. asset strategy, Target Product Profile). A date for the 3-hour PEP Workshop mid-way through the six-to-eight-week process. This facilitated and highly interactive cross-function Workshop, live or virtual, focuses on the information the internal team needs to understand from patients or the patient community, by when, and for what purpose. The Workshop output is compiled and analyzed together with Legacy’s deep experience and understanding of the Patient Engagement landscape. Final outputs are discussed with the internal core and full team, and the plan is then integrated into the asset strategy.
Many leaders and team members within organizations have concerns that “keep them up at night regarding what patients really need and what”. Often, they realize their teams may be making assumptions about patient perspectives. By bringing internal stakeholders together, we find that these concerns are not only validated across team members but concerted efforts to ensure patients’ voice as brought into the process of development is truly desired and needed and through the PEP process and resulting plan, teams now have an effective methodology and plan to address the issues that will help leaders feel confident that the products they are development will truly meet the needs of patients.